In trials, patients who had at least 50% scalp hair loss for more than six months who were treated with Olumiant, with 17-22% of those at the 2mg dose and 32-35% at the 4mg dose achieving at least ...

Eli Lilly and Incyte have another rival in the rear-view mirror for Olumiant in alopecia areata after Pfizer reported that its ritlecitinib improved scalp hair regrowth in a late-stage trial.